267 related articles for article (PubMed ID: 9476567)
41. Glycoprotein IIb/IIIa antagonists: do they have a role in the management of unstable angina?
Redwood S; Marber M; Jackson G
Int J Clin Pract; 1999 Dec; 53(8):618-22. PubMed ID: 10692757
[TBL] [Abstract][Full Text] [Related]
42. The anti-GPIIb-IIIa agents: fundamental and clinical aspects.
Coller BS; Anderson KM; Weisman HF
Haemostasis; 1996 Oct; 26 Suppl 4():285-93. PubMed ID: 8979134
[TBL] [Abstract][Full Text] [Related]
43. [Inhibitors of GPIIb/IIIa platelet receptors].
Chanu B
Arch Mal Coeur Vaiss; 1999 Jul; 92(7):893-902. PubMed ID: 10443310
[TBL] [Abstract][Full Text] [Related]
44. New antiplatelet agents.
White HD; French JK; Ellis CJ
Aust N Z J Med; 1998 Aug; 28(4):558-64. PubMed ID: 9777140
[TBL] [Abstract][Full Text] [Related]
45. Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selection.
Atwater BD; Roe MT; Mahaffey KW
Drugs; 2005; 65(3):313-24. PubMed ID: 15669877
[TBL] [Abstract][Full Text] [Related]
46. [Tirofiban (Aggrastat). A non-peptide glycoprotein IIb/IIIa receptor inhibitor].
Rasmussen S; Husted SE
Ugeskr Laeger; 2001 Jan; 163(4):461-5. PubMed ID: 11218789
[TBL] [Abstract][Full Text] [Related]
47. Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromes.
Chew DP; Roffi M; Topol EJ
Prog Cardiovasc Dis; 2001; 44(3):195-206. PubMed ID: 11727277
[TBL] [Abstract][Full Text] [Related]
48. Low-molecular-weight heparin and other antithrombotic agents in the setting of a fast-track revascularization in unstable coronary artery disease.
Bassand JP
Haemostasis; 2000; 30 Suppl 2():114-21; discussion 106-7. PubMed ID: 11251354
[TBL] [Abstract][Full Text] [Related]
49. [Stratification of cardiac risk in unstable angina: value of troponin measurements].
Chérif A; Messaoudi H; Mourali S; Ezzar T; Boussaada R; Mechmèche R
Tunis Med; 2002 Oct; 80(10):581-3. PubMed ID: 12632750
[TBL] [Abstract][Full Text] [Related]
50. Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes.
Faraday N; Braunstein JB; Heldman AW; Bolton ED; Chiles KA; Gerstenblith G; Schulman SP
Platelets; 2004 Feb; 15(1):9-14. PubMed ID: 14985171
[TBL] [Abstract][Full Text] [Related]
51. A process for ensuring optimal cardiovascular intervention and identifying candidates for glycoprotein IIb/IIIa receptor inhibitor therapy.
Millhouse FG; Shaw RE
Am J Cardiol; 2000 Mar; 85(5A):27B-31B. PubMed ID: 11076128
[TBL] [Abstract][Full Text] [Related]
52. Antithrombotic therapy of unstable angina and non-Q-wave myocardial infarction.
Ferrario M; Merlini PA; Lucreziotti S; Poli A; Cantù F; Gobbi G; Bramucci E; Mussini A; Ardissino D
Int J Cardiol; 1999 Apr; 68 Suppl 1():S63-71. PubMed ID: 10328613
[TBL] [Abstract][Full Text] [Related]
53. Design and methodology of the PURSUIT trial: evaluating eptifibatide for acute ischemic coronary syndromes. Platelet Glycoprotein IIb-IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
Harrington RA
Am J Cardiol; 1997 Aug; 80(4A):34B-38B. PubMed ID: 9291244
[TBL] [Abstract][Full Text] [Related]
54. Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study.
Théroux P; Kouz S; Roy L; Knudtson ML; Diodati JG; Marquis JF; Nasmith J; Fung AY; Boudreault JR; Delage F; Dupuis R; Kells C; Bokslag M; Steiner B; Rapold HJ
Circulation; 1996 Sep; 94(5):899-905. PubMed ID: 8790023
[TBL] [Abstract][Full Text] [Related]
55. Intravenous glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: lessons from recently conducted randomized clinical trials.
Boersma E; Westerhout CM
Curr Opin Investig Drugs; 2004 Mar; 5(3):313-9. PubMed ID: 15083598
[TBL] [Abstract][Full Text] [Related]
56. Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: part 1: the evidence of benefit.
Zimarino M; De Caterina R
J Cardiovasc Pharmacol; 2004 Mar; 43(3):325-32. PubMed ID: 15076214
[TBL] [Abstract][Full Text] [Related]
57. Antiplatelet therapy for ischemic heart disease.
Lange RA; Hillis LD
N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308
[No Abstract] [Full Text] [Related]
58. Platelet glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: initiate treatment early or wait for the catheterization laboratory?
Harnick DJ; Vorchheimer DA
Curr Cardiol Rep; 2001 Sep; 3(5):355-61. PubMed ID: 11504571
[TBL] [Abstract][Full Text] [Related]
59. [Coronary syndromes in the elderly].
Bounhoure JP; Carrié D; Puel J
Bull Acad Natl Med; 2006; 190(4-5):807-16; discussion 816, 873-6. PubMed ID: 17195608
[TBL] [Abstract][Full Text] [Related]
60. Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease.
Chesebro JH; Badimon JJ
N Engl J Med; 1998 May; 338(21):1539-41. PubMed ID: 9593795
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
